The study recruited 32 patients for the NAION group, which included 3 patients with bilateral disease. The mean period between disease onset and OCT examination was 142 days (with a range of 34 to 289 days). Patients with insufficient follow-up periods or inadequate OCT imaging quality were excluded from the study. The age-matched control group included 40 participants. The average age of the NAION study group was 59.97 ± 8.27 years. The mean age of participants in the control group was 59.08 ± 14.92 years. The average axial length was 23.8 ± 1.15 mm in the NAION group and 24.1 ± 1.03 mm in the age-matched control group.
Table 1 compares the demographic characteristics of the NAION and age-matched control groups. No significant differences existed in age distribution (
P = 0.762), gender (
P = 0.316), axial length (
P = 0.28), and systemic diseases, such as hypertension (
P = 0.638) or DM (
P = 0.761).
As indicated in
Table 2, the average PCT was 197.09 ± 38.09 µm in the affected eye of the patients with NAION, 196.52 ± 38.47 µm in the fellow eye of the patients with NAION, and 153.53 ± 29.92 µm in the control group. The PCT in the affected or fellow eye of all patients with NAION was significantly thicker than that in the control group (
P < 0.001) Conversely, no significant differences in mean PCT existed between the affected and fellow eye in the patients with unilateral NAION (
P = 0.174).
Furthermore, we investigated the average PCT in the four quadrants (superior, inferior, temporal, and nasal). Our results indicated that the PCT values in all sectors were significantly thicker in both the affected and fellow eye of patients with NAION than those in the control group (all
P < 0.005). Additionally, no significant differences existed in the PCT values of the four quadrants between the affected eye and fellow eye in the patients with NAION. We also found that the PCT of the superior quadrant was significantly thicker than that of the inferior quadrant in NAION eyes, fellow eyes, and control eyes (
Fig. 2).
We conducted a regression to investigate the predisposing factors of NAION (
Table 3). In the univariate analysis, a diagnosis of NAION was positively associated with PCT (
P < 0.001, odds ratio [OR] = 1.417, per 10 µm, 95% confidence interval [CI] = 1.186–1.692), and no significant associations existed with age (
P = 0.759), gender (
P = 0.317), axial length (
P = 0.274), hypertension (
P = 0.638), or DM (
P = 0.761). In the multivariate analysis, we adjusted for age, gender, and axial length. However, PCT remained significantly associated with the diagnosis of NAION (
P < 0.001, OR = 1.426, per 10 µm, 95% CI = 1.187–1.714). Furthermore, we investigated the relationship between mean PCT and final visual outcomes, including visual acuity and visual field (
Table 4). After adjustments for other variables, including age, gender, DM, hypertension, and axial length, no significant correlation existed among the mean PCT, final visual acuity (
P = 0.063), and visual field (
P = 0.804).